XJPX3001
Market cap403mUSD
Jan 17, Last price
1,955.00JPY
1D
-1.31%
1Q
-2.98%
Jan 2017
43.01%
Name
Katakura Industries Co Ltd
Chart & Performance
Profile
Katakura Industries Co.,Ltd. engages in the textile, pharmaceutical, machinery, real estate, and life solutions businesses in Japan. The company manufactures and sells undergarments, hosiery products, aprons, and relaxing garments, as well as various functional fibers, such as the water-soluble fiber solvron and the thermal resistant NITIVY ALF. It also engages in the manufacture and sale of pharmaceuticals for treating cardiovascular illnesses comprising Frandol for the treatment of angina pectoris; and Frandol Tape, a heart medicine. In addition, the company manufactures and sells environment-related equipment (washers) and cutting oil–related products, fire engines and firefighting-related equipment, and agricultural machinery, as well as car parts. Further, it provides commercial facility management services; and leases and develops various real estate lands. Additionally, the company offers agriculture-related products, food products, nursing care equipment, and general building maintenance and flower/tree planting services, as well as operates plant and pet specialty shops. The company was formerly known as Katakura Silk Spinning Co., Ltd. and changed its name to Katakura Industries Co.,Ltd. in November 1943. Katakura Industries Co.,Ltd. was founded in 1873 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 39,972,000 16.62% | 34,274,000 -8.91% | |||||||
Cost of revenue | 35,903,000 | 25,933,000 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 4,069,000 | 8,341,000 | |||||||
NOPBT Margin | 10.18% | 24.34% | |||||||
Operating Taxes | 1,331,000 | 1,234,000 | |||||||
Tax Rate | 32.71% | 14.79% | |||||||
NOPAT | 2,738,000 | 7,107,000 | |||||||
Net income | 3,045,000 8.09% | 2,817,000 -43.13% | |||||||
Dividends | (532,000) | (665,000) | |||||||
Dividend yield | 0.98% | 1.15% | |||||||
Proceeds from repurchase of equity | (239,000) | (165,000) | |||||||
BB yield | 0.44% | 0.29% | |||||||
Debt | |||||||||
Debt current | 5,122,000 | 5,663,000 | |||||||
Long-term debt | 7,344,000 | 8,668,000 | |||||||
Deferred revenue | 926,000 | 1,073,000 | |||||||
Other long-term liabilities | 15,308,000 | 15,580,000 | |||||||
Net debt | (52,934,000) | (50,544,000) | |||||||
Cash flow | |||||||||
Cash from operating activities | 3,576,000 | (712,000) | |||||||
CAPEX | (1,110,000) | (1,046,000) | |||||||
Cash from investing activities | 606,000 | 3,623,000 | |||||||
Cash from financing activities | (4,062,000) | (3,262,000) | |||||||
FCF | (4,367,000) | 4,343,000 | |||||||
Balance | |||||||||
Cash | 29,743,000 | 36,252,000 | |||||||
Long term investments | 35,657,000 | 28,623,000 | |||||||
Excess cash | 63,401,400 | 63,161,300 | |||||||
Stockholders' equity | 86,301,000 | 81,303,000 | |||||||
Invested Capital | 53,299,600 | 51,058,700 | |||||||
ROIC | 5.25% | 14.43% | |||||||
ROCE | 3.20% | 6.73% | |||||||
EV | |||||||||
Common stock shares outstanding | 33,139 | 33,187 | |||||||
Price | 1,638.00 -5.65% | 1,736.00 -29.57% | |||||||
Market cap | 54,281,721 -5.78% | 57,611,766 -30.38% | |||||||
EV | 15,988,721 | 21,638,766 | |||||||
EBITDA | 6,728,000 | 11,019,000 | |||||||
EV/EBITDA | 2.38 | 1.96 | |||||||
Interest | 108,000 | 121,000 | |||||||
Interest/NOPBT | 2.65% | 1.45% |